Pricing

Log inSign up

Prilenia

1 follower

‌

Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.

Industries

Biotechnology

Headquarters

Herzliya, Israel

Employees

11-50

Links

Org chart

Michael R. Hayden
CEO

Michael R. Hayden

Collapse
Henk Schuring
Chief Regulatory & Commercialization Officer
Limor Ben Har
COO
Anne Sullivan
Chief Business Officer
Yael Cohen
SVP, Head of Clinical Operations
Elena Berelovich
SVP, Head of CMC
Michal Geva
SVP, Head of Research
Leehee Navon-Perry
Director, Medical Writing
KC
Kelly Chen
Senior Director, Head of Biometrics
Andres Cruz-Herranz
Director of Clinical Development
Noga Gershoni-Emek
Scientific Affairs Manager
May Meltzer
Scientific IP Lead
Rob Lauzen
Chief Financial Officer

Teams

+3

Leadership Team

6 members

+2

Commercial Strategy Team

5 members

+1

Clinical Development Team

4 members

Similar companies

Immunome

2 followers

BeiGene

19 followers

Ascendis Pharma

8 followers

Kornit Digital

1 follower

Vicarius

1 follower

Tessera Therapeutics

2 followers

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Floyd Holdings

2 followers

Thrive Capital

26 followers

Explore companies